Search results
Arcturus Therapeutics (NASDAQ:ARCT) Stock Price Down 4.4%
ETF DAILY NEWS· 4 days agoArcturus Therapeutics Holdings Inc. (NASDAQ:ARCT – Get Free Report)’s stock price was down 4.4% during mid-day trading on Friday . The company traded as ...
Worried you missed the Nvidia bandwagon? Here are some alternative stocks.
MarketWatch via Yahoo Finance· 4 days agoAMD’s P/E is also a bit lower than it was a year ago — this is another case where the share price...
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Moderna, Inc. - ...
FOX 23 News Albany· 4 days agoPomerantz LLP is investigating claims on behalf of investors of Moderna, Inc. ("Moderna" or the "Company") (NASDAQ: MRNA). Such investors are advised to contact Danielle Peyton ...
Gateway - Quartz
Quartz· 10 hours agoModerna said Tuesday that its updated COVID-19 vaccine demonstrated a stronger immune response than its current jab in results from a phase-3 clinical trial. The pharma Moderna stock ...
Moderna's (MRNA) Next-Gen COVID-19 Jab Study Meets Efficacy Goal
Zacks· 4 days agoData from a late-stage study shows that Moderna's (MRNA) next-generation COVID-19 vaccine achieved non-inferior vaccine efficacy against COVID-19 when compared with its previously approved bivalent COVID-19 vaccine.
Here’s Why RGAIA Considers Maravai LifeSciences Holdings’ (MRVI) Margin Structure as the Best
Insider Monkey via Yahoo Finance· 2 days agoRGA Investment Advisors, an investment management company released its first quarter 2024 investor...
B.Riley lifts Vaxart shares target on BARDA award By Investing.com
Investing.com· 5 days agoOn Friday, B.Riley raised the price target for Vaxart Inc. (NASDAQ:VXRT) shares to $2.50, up from...
Willner & Heller LLC Purchases New Holdings in Pfizer Inc. (NYSE:PFE)
ETF DAILY NEWS· 2 days agoWillner & Heller LLC acquired a new position in Pfizer Inc. (NYSE:PFE – Free Report) in the 4th quarter, HoldingsChannel reports. The fund acquired 19,822 shares of the biopharmaceutical company ...
Cantor Fitzgerald Reiterates “Overweight” Rating for Pfizer (NYSE:PFE)
ETF DAILY NEWS· 13 hours agoCantor Fitzgerald’s price target indicates a potential upside of 64.17% from the stock’s previous close. Morgan Stanley upped their target price ...
7 Struggling Stocks to Sell Before July 2024
InvestorPlace via Yahoo Finance· 7 days agoThe stock market’s surge continues, with several major market indices making new all-time highs recently. The explosion of artificial intelligence and...
